These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31138731)

  • 41. Investigation of some commercially available spacer devices for the delivery of glucocorticoid steroids from a pMDI.
    Williams RO; Patel AM; Barron MK; Rogers TL
    Drug Dev Ind Pharm; 2001 May; 27(5):401-12. PubMed ID: 11448047
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved delivery of inhaled steroids to the large and small airways.
    Leach CL
    Respir Med; 1998 Jun; 92 Suppl A():3-8. PubMed ID: 9850357
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects.
    Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG
    Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Targeting inhaled steroids.
    Leach C
    Int J Clin Pract Suppl; 1998 Sep; 96():23-7. PubMed ID: 10344030
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers.
    Gupta A; Stein SW; Myrdal PB
    J Aerosol Med; 2003; 16(2):167-74. PubMed ID: 12823910
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology.
    Kleinstreuer C; Shi H; Zhang Z
    J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the efficacy and safety of high doses of beclometasone dipropionate suspension for nebulization and beclometasone dipropionate via a metered-dose inhaler in steroid-dependent adults with moderate to severe asthma.
    Grzelewska-Rzymowska I; Kroczynska-Bednarek J; Zarkovic J
    Respir Med; 2003 Feb; 97 Suppl B():S21-6. PubMed ID: 12593524
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhaled beclometasone dipropionate/formoterol extra-fine fixed combination in the treatment of asthma: evidence and future perspectives.
    Fabbri LM; Nicolini G; Olivieri D; Papi A
    Expert Opin Pharmacother; 2008 Feb; 9(3):479-90. PubMed ID: 18220498
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Beclomethasone relative availability of oral versus inhaled beclomethasone dipropionate from an HFA-134A metered dose inhaler.
    Soria I; Harrison LI; Machacek JH; Cline AC; Stampone PA
    Biopharm Drug Dispos; 1998 Jul; 19(5):297-302. PubMed ID: 9673781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic comparison of beclomethasone dipropionate extrafine aerosol from two inhaler devices in children with asthma.
    Harrison LI; Kurup S; Chen LZ; Ekholm BP; Wighton TG; Shapiro GG
    Eur J Clin Pharmacol; 2002 Jun; 58(3):191-5. PubMed ID: 12107605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic comparison of inhaled fixed combination vs. the free combination of beclomethasone and formoterol pMDIs in asthmatic children.
    Chawes BL; Piccinno A; Kreiner-Møller E; Vissing NH; Poorisrisak P; Mortensen L; Nilson E; Bisgaard A; Dossing A; Deleuran M; Skytt NL; Samandari N; Sergio F; Ciurlia G; Poli G; Acerbi D; Bisgaard H
    Br J Clin Pharmacol; 2013 Apr; 75(4):1081-8. PubMed ID: 22978252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer.
    Clearie KL; Williamson PA; Vaidyanathan S; Du Bois J; Nell H; Lipworth BJ
    Br J Clin Pharmacol; 2010 Jun; 69(6):637-44. PubMed ID: 20565455
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Home-made spacer as an auxiliary device in administration of beclomethasone via pressurized metered dose inhaler for asthma control. A randomized controlled pragmatic trial.
    Schor D; Rizzo JÂ; Medeiros D; Dela Bianca AC; Silva AR; Nunes C; Morais-Almeida M; Sarinho E
    Respir Med; 2017 May; 126():52-58. PubMed ID: 28427550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man.
    Daley-Yates PT; Price AC; Sisson JR; Pereira A; Dallow N
    Br J Clin Pharmacol; 2001 May; 51(5):400-9. PubMed ID: 11421996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler(®)) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trial.
    Kanniess F; Scuri M; Vezzoli S; Francisco C; Petruzzelli S
    Pulm Pharmacol Ther; 2015 Feb; 30():121-7. PubMed ID: 25088067
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler.
    Nair A; Menzies D; Hopkinson P; McFarlane L; Lipworth BJ
    Br J Clin Pharmacol; 2009 Feb; 67(2):191-8. PubMed ID: 19220273
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic exposure to inhaled beclometasone/formoterol DPI is age and body size dependent.
    Chawes BL; Govoni M; Kreiner-Møller E; Vissing NH; Poorisrisak P; Mortensen L; Nilsson E; Bisgaard A; Dossing A; Deleuran M; Skytt NL; Samandari N; Piccinno A; Sergio F; Ciurlia G; Poli G; Acerbi D; Singh D; Bisgaard H
    Respir Med; 2014 Aug; 108(8):1108-16. PubMed ID: 24993817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.
    Leach CL; Kuehl PJ; Chand R; Ketai L; Norenberg JP; McDonald JD
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):195-200. PubMed ID: 22374204
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
    Lewis DA; Young PM; Buttini F; Church T; Colombo P; Forbes B; Haghi M; Johnson R; O'Shea H; Salama R; Traini D
    Eur J Pharm Biopharm; 2014 Jan; 86(1):31-7. PubMed ID: 23523547
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metered-dose inhaler formulations with beclomethasone-17,21-dipropionate using the ozone friendly propellant R 134a.
    Steckel H; Müller BW
    Eur J Pharm Biopharm; 1998 Jul; 46(1):77-83. PubMed ID: 9700025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.